|
YLPM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.80569997737723E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.17540005401185E-09 |
| Normal-vs-Stage2 |
3.34520000000449E-06 |
| Normal-vs-Stage3 |
3.50159999999988E-05 |
| Normal-vs-Stage4 |
6.71669999952051E-07 |
| Stage1-vs-Stage2 |
7.498000E-01 |
| Stage1-vs-Stage3 |
7.452400E-01 |
| Stage1-vs-Stage4 |
2.225000E-01 |
| Stage2-vs-Stage3 |
9.778200E-01 |
| Stage2-vs-Stage4 |
3.013400E-01 |
| Stage3-vs-Stage4 |
3.357400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.01130001331995E-09 |
| Normal-vs-AfricanAmerican |
1.21350000048537E-08 |
| Normal-vs-Asian |
2.813400E-04 |
| Caucasian-vs-AfricanAmerican |
5.153400E-01 |
| Caucasian-vs-Asian |
6.496000E-01 |
| AfricanAmerican-vs-Asian |
7.482000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.37140365309119E-11 |
| Normal-vs-Female |
9.083700E-03 |
| Male-vs-Female |
3.295200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.56349999999883E-06 |
| Normal-vs-Extreme_Weight |
9.94530013898043E-10 |
| Normal-vs-Obese |
1.55423999999016E-05 |
| Normal-vs-Extreme_Obese |
1.71057999999169E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.374800E-01 |
| Normal_Weight-vs-Obese |
3.764200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.901800E-01 |
| Extreme_Weight-vs-Obese |
7.923900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.061800E-01 |
| Obese-vs-Extreme_Obese |
1.786430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.789970E-02 |
| Normal-vs-Age(41-60Yrs) |
8.93680000002561E-07 |
| Normal-vs-Age(61-80Yrs) |
3.54010043501773E-10 |
| Normal-vs-Age(81-100Yrs) |
2.40009999652457E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.037000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.554600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.682400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.923700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.776400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.582200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.44249998004875E-09 |
| Normal-VS-Type2 PRCC |
1.01989972023375E-10 |
| Normal-VS-KIRP CIMP |
1.113990E-01 |
| Normal-VS-Unclassified PRCC |
3.978400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.239370E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.234800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.937210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.022400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.060300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.230200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55210289065622E-11 |
| Normal-vs-N1 |
7.203400E-03 |
| Normal-vs-N2 |
1.046820E-04 |
| N0-vs-N1 |
8.302500E-02 |
| N0-vs-N2 |
4.539200E-01 |
| N1-vs-N2 |
2.252200E-01 |
|
|
